# Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma.

> **NCT00040573** · PHASE1,PHASE2 · COMPLETED · sponsor: **TransMolecular** · enrollment: 18 (—)

## Conditions studied

- Glioma
- Brain Neoplasm

## Interventions

- **DRUG:** 131I-TM-601

## Key facts

- **NCT ID:** NCT00040573
- **Lead sponsor:** TransMolecular
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** —
- **Final completion:** 2003-08
- **Target enrollment:** 18 (—)
- **Last updated:** 2009-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00040573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00040573, "Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00040573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*